Study compares two common blood pressure drugs

2025 年 10 月 24 日 health, medicine

High blood pressure, also called hypertension, is a common health problem that affects many people around the world. If left untreated, it can lead to serious health issues like heart attacks, strokes, and kidney problems. There are many types of medications used to control blood pressure, and a new study from Geisinger Medical Center has [.] The post Study compares two common blood pressure drugs appeared first on Knowridge Science Report.

Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision

2025 年 10 月 4 日 business, finance, healthcare, medicine, pharmaceuticals

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best stocks to buy under $20. On September 19, Syndax Pharmaceuticals announced a major milestone: the National Comprehensive Cancer Network/NCCN updated its Clinical Practice Guidelines in Oncology/NCCN Guidelines for Acute Myeloid Leukemia/AML to include Revuforj (revumenib). Revumenib received a Category 2A recommendation for the treatment of relapsed […]